1. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016; 375: 2369-2379. doi: 10.1056/NEJMra1600266
2. Falony G, Joosens M, Vieira-Colomer S, Wang J, Dazzi Y, Faust M, et al. Population level analysis of gut microbiome variation. Science. 2016; 352: 560-564. doi: 10.1126/science.aad3503
3. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012; 10(11): 735-742. doi: 10.1038/nrmicro2876
4. Gribble FM, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocriniol. 2019; 15: 226-237. doi: 10.1038/s41574-019-0168-8
5. Skibicka KP, Dickson SL. Enteroendocrine hormones-Central effects on behaviour. Curr Opin Pharmacol. 2013; 13: 977-982. doi: 10.1016/j.coph.2013.09.004
6. Bravo JA, Forsythe P, Chew MV, Escavarage E, Savignac HM, Dinan TG, et al. Investigation of Lactobacillus strain regulates emotional and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011; 108: 16050-16055. doi: 10.1073/pnas.1102999108
7. Neufeld KA, Foster JA. Effects of gut microbiota on the brain : Implications for Psychiatry. J Psychiatry Neurosci. 2009; 34: 230-231.
8. Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011; 23: 1132-1139. doi: 10.1111/j.1365-2982.2011.01796.x
9. Howard RH. Vagus nerve stimulation .Curr Behav Neurosci Rep. 2014; 1: 64-73. doi: 10.1007/s40473-014-0010-5
10. Kaur K, Allahbadia GN, Mandeep S. An update on etiopathogenesis and management of obesity. Obes Control Therap. 2016; 3(1): 1-17. doi: 10.15226/2374-8354/2/2/00123
11. Kulvinder Kochar Kaur,Allahbadia GN,Singh Mandeep. Have Probiotics and Synbiotics passed the test of time to be implemented in management of obesity and related metabolic disorders-a comprehensive review. Adv Obes Weight Manag Control. 2019; 9(1): 21-28. doi: 10.15406/aowmc.2019.09.00269
12. Kaur KK, Allahbadia GN, Singh M. Will probiotics provide the answer for therapy of non-alcoholic fatty liver disease (NAFLD)? – A Systematic Review. Biochem Physiol. 2020; 9: 1-14.
13. Kaur K, Allahbadia GN, Singh M. Advances in probiotics use with the utilization of engineering technology for diseases beyond obesity, non alcoholic fatty liver disease, to treat neurodegenerative diseases, metabolic diseases like Type1 diabetes, infectious diseases and infections – A systematic review. J Endocrinol. 2020; 4(1): 1-12. doi: 10.23880/oaje-16000151-1./2020
14. Kaur KK, Allahbadia GN, Singh M. Weight loss Associated with high protein intake in obesity: Interactions of gut microbiota in protein sources influencing this positive effect. Acta Scientific Nutritional Health. 2018; 2(7): 80-89.
15. Coccurello R. Anhedonia in depression symptamatology: Appetite dysregulation and defective brain reward processing. Behav Brain Res. 2019; 372: 112041. doi: 10.1016/j.bbr.2019.112041
16. Dickerson E, Severance E, Yolken R.The: Microbiome, immunity and Schizophrenia abd bipolar disorder. Behav Brain Immunol. 2017; 62: 46-52. doi: 10.1016/j.bbi.2016.12.010
17. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology. 2002; 122: 1140-1156. doi: 10.1053/gast.2002.32392
18. La Fata G, Weber P, Mohajeri MH. Probiotics and the Gut immune system: Indirect regulation. Probiotics Antimicrob Proteins. 2018; 10: 11-21. doi: 10.1007/s12602-017-9322-6
19. Fransen F, Van Beek AA, Borghuis T, El Aidy S, Hugerholtz F, Van de Gaast de JonghC, et al. Aged gut microbiota contributes to systematical inflammaging after transfer to germ free mice. Front Immunol. 2017; 8: 1385. doi: 10.3389/fimmu.2017.01385
20. Kutak-Bejda A, Bejda G, Waszkiewicz N. Antidepressants for irritable bowel syndrome-A systematic review. Pharmacol Rep. 2017; 69: 1366-1379. doi: 10.1016/j.pharep.2017.05.014
21. Riboni FV, Belzung C. Stress and psychiatric disorders: From categorical to dimensional approaches. Curr Opin Behav Sci. 2017; 14: 72-77. doi: 10.1016/j.cobeha.2016.12.011
22. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N,Yu X, et al. Postnatal microbial colonization programs the hypothalamo-pituitary-adrenal system for stress response in mice. J Physiol. 2004; 558: 263-275. doi: 10.1113/jphysiol.2004.063388
23. Hasan Mohajeri M, La Fata G,Steinert RE, Weber P. Relationship between the gut microbiome and brain function. Nutr Rev. 2018; 76: 481-496. doi: 10.1093/nutrit/nuy009
24. Ogbonnaya ES, Clarke G,Shanahan F, Dinan TG, Cryan JF, O’Leary OF. Adult hippocampal neurogenesis is regulated by the Microbiome. Biol Psychiatry Neurosci. 2015; 78: e7-e9. doi: 10.1016/j.biopsych.2014.12.023
25. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the Probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010; 170(4): 1179-1188. doi: 10.1016/j.neuroscience.2010.08.005
26. Bharwani A, Mian MF, Surette MG, Bienenstock J, Forsythe P. Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. BMC Med. 2017; 15: 7. doi: 10.1186/s12916-016-0771-7
27. Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid; production by culturable bacteria from the intestine. J Appl Microbiol. 2012; 113: 411-417. doi: 10.1111/j.1365-2672.2012.05344.x
28. Li H, Wang P, Huang L, Li P, Zhang D. Effects of regulating Gut Microbiota on the serotonin metabolism in the chronic unpredictable mild stress rat model. Neurogastroenterol Motil. 2019; 31: e13677. doi: 10.1111/nmo.13677
29. Kelly JR, Borre Y, O’Brien C, Patterson E, El Aidy S, Deane J, et al. Transferring the blues: Depression associated Gut Microbiota induces neurobehavioral changes in the rat. J Psychiatry Res. 2016; 82: 109-118. doi: 10.1016/j.jpsychires.2016.07.019
30. Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, et al. Gut Microbiome remodelling induces depressive like behaviours through a pathway mediated by the host’s metabolism. Mol Psychiatry. 2016; 21: 786-796. doi: 10.1038/mp.2016.44
31. Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, et al. Inflammasome signalling affects anxiety and depressive like behaviours and Gut Microbiome composition. Mol Psychiatry. 2016; 21: 797-805. doi: 10.1038/mp.2016.46
32. Valles-Colomer M, Faloney G, Darzy Y, Tigchelaar EF, Wang J, Tito RY, et al. The neuroactive potential of the human Gut Microbiota in the quality of life and depression. Nat Microbiol. 2019; 4: 623-632. doi: 10.1038/s41564-018-0337-x
33. O’Mahoney SM, Clarke G, Borre YE, Cryan JF, Dinan TG. Serotonin, tryptophan metabolism and the brain-Gut Microbiome axis. Behav Brain Res. 2015; 277: 32-48. doi: 10.1016/j.bbr.2014.07.027
34. Marrone MC, Coccurello R. Dietary fatty acids and microbiota–brain communication in neuropsychiatric diseases. Biomolecules. 2020; 10: 12. doi: 10.3390/biom10010012
35. Thion MS, Low D, Silvin A, Chen J, Grisel P, Schulte–Schrepping J, et al. Microbiome influences prenatal and adult microglia in sex specific manner. Cell. 2018; 172: 500-516. doi: 10.1016/j.cell.2017.11.042
36. Heneka MT. Microglia take centre stage in neurodegenerative disease. Nat Rev Immunol. 2019; 19: 79-80. doi: 10.1038/s41577-018-0112-5
37. Bilbo SD, Block CL, BoltonJL, Hanamsagar R,Tran PK. Beyond infection-Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. Exp Neurol. 2018; 299: 241-251. doi: 10.1016/j.expneurol.2017.07.002
38. Bergdolt L, Dunaevsky A. Brain changes in a maternal immune activation model of neurodevelopmental brain disorders. Prog Neurobiol. 2019; 175: 1-19. doi: 10.1016/j.pneurobio.2018.12.002
39. Dinan TG, Cryan JF. Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinology. Psychoneuroendocrinology. 2012; 37: 1369-1378. doi: 10.1016/j.psyneuen.2012.03.007
40. Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K, et al. Microglial activation in young adults with autism spectrum disorders. JAMA Psychiatry. 2013; 70: 49-58. doi: 10.1001/jamapsychiatry.2013.272
41. Santos S, Oliveira A, Lopez C. Systematic review of saturated fatty acids on inflammation and circulating levels of adipokines.Nutr Res. 2013; 33: 687-695. doi: 10.1016/j.nutres.2013.07.002
42. Valdearcos M, Douglas JD, Robblee MM, Dorfan MD, Stifler DR, Bennett ML, et al. Microglial inflammatory signalling orchestrates the hypothalamic immune response to dietary excess and mediates obesity susceptibility. Cell Metab. 2017; 26(1): 185-197.e3. doi: 10.1016/j.cmet.2017.05.015
43. Kaaur KK, Allahbadia GN, Mandeep S. Current advances in pathogenesis in obesity: Impact of hypothalamic glioses. J Obes Weight Loss. 2018; 3: 008.
44. Kaur KK, Allahbadia GN, Singh M. Hypothalamic inflammation and glioses as aetiopathogenetic factor inhigh fat diet induced obesity and varioustherapeutic options to resolve it. Obes Res Open J. 2017; 4(2): 44-60. doi: 10.17140/OROJ-4-132
45. Kaur KK, Allahbadia GN, Singh M. Synthesis and functional significance of Poly Unsaturated fatty acids (PUFA’s) in body. Acta Scientific Nutritional Health. 2018; 4: 43-50.
46. Bhagvan NV, Ha CE. Essentials of Medical Biochemistry; Cambridge MA,USA; Academic Press: 2011.
47. Lee JM, Lee H, Kang SB, Park WJ. Fatty acid desaturases, poly unsaturated fatty acids regulation and biotechnological advances.Nutrients. 2016; 8: 23. doi: 10.3390/nu8010023
48. Russo GL. Dietary n-6 and n-3 poly unsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol. 2009; 77: 937-946. doi: 10.1016/j.bcp.2008.10.020
49. Simopoulos AP. Evolutionary aspect of diet: The omega -6/ omega-3 ratio and the brain. Mol Neurobiol. 2011; 44: 203-215. doi: 10.1007/s12035-010-8162-0
50. Brash AR. Arachidonic acid as a bioactive molecule. J Clin Investig. 2001; 107: 1139-1145. doi: 10.1172/JCI13210
51. Spite M, Claria J, Serhan CN. Resolvins,specialized pro-resolving lipid mediators, and their potential role in metabolic diseases.Cell Metab. 2014; 19: 21-36. doi: 10.1016/j.cmet.2013.10.006
52. Riciotti E, Fitzergald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31: 986-1000. doi: 10.1161/ATVBAHA.110.207449
53. Yang X, Sun L, Zhao A, Hu X, Qing Y, Jiang J, et al. Serum fatty acids patterns in patients with schizophrenia: A targeted metabolomic study. Transl Psychiatry. 2017; 7: e1176. doi: 10.1038/tp.2017.152
54. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014; 510: 92-101. doi: 10.1038/nature13479
55. Bozzatello P, Brignolo E, De Grandi E, Bellino S. Supplementation with omega -3 fatty acids in psychiatric disorders: A review of literature data. J Clin Med. 2016; 5: 67. doi: 10.3390/jcm5080067
56. Berger ME, Smesny S, Kim SW, Davey CG, Rice C, Samayi Z, et al. Omega -6 to omega -3 poly unsaturated fatty acids ratio and subsequent mood disorders in young people with at risk mental states: A 7 year longitudinal study. Transl Psychiatry. 2017; 7: e1220. doi: 10.1038/tp.2017.190
57. Kaliannan K, Li XY, Wang B, Pan Q, Chen CY, Hao L, et al. Multi-omic analysis in transgenic mice implicates omega -6/omega -3 fatty acids imbalance as a risk factor for chronic disease. Commun Biol. 2019; 2: 1-18. doi: 10.1038/s42003-019-0521-4
58. Kaliannan K, Wang B, Li XY, Kim KJ, Kang JX. A host-metabolome interaction mediates the opposing effects of omega -6 and omega -3 fatty acids on metabolic endotoxaemia. Sci Rep. 2015; 5: 11276. doi: 10.1038/srep11276
59. Portnoy J, Raine A, Liu J, Hibbein JR. Reduction of intimate partner violence resulting from supplementing children with omega -3 fatty acids: A randomized, double blind, placebo controlled, stratified parallel group trial.Aggress Behav. 2008; 44: 491-500. doi: 10.1002/ab.21769
60. Robertson RC, Kaliannan K, Strain CR, Ross RP, Stanton C, Kang JX. Maternal omega-3 fatty acids regulating offspring obesity through persistent modulation of gut microbiota. Metabolome. 2018; 6: 95. doi: 10.1186/s40168-018-0476-6
61. Pusceddu MM, El Aidy S, Crispie E, O’Sullivan O, Cotter P, Stanton C, et al. N-3 poly unsaturated fatty acids (PUFA),-reverse the impact of early –life stress on gut microbiota. PLoS One. 2015; 10: e0139721. doi: 10.1371/journal.pone.0139721
62. Lin P, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acids composition in patients with depression. Biol Psychiatry. 2010; 68: 140-147. doi: 10.1016/j.biopsych.2010.03.018
63. Pusceddu MM, Kelly P, Stanton C, Cryan JF, Dinan TG. N-3 polyunsaturated fatty acids through the lifespan: Implications in psychopathology. Int J Neuropsychopharmacol. 2016; 19(12): pyw078. doi: 10.1093/ijnp/pyw078
64. Jory J. Abnormal fatty acids in Canadian children with autism. Nutrition. 2016; 32: 474-477. doi: 10.1016/j.nut.2015.10.019
65. Pawelczyk T, Grancow-Grabka M, Trafalska E, Szemraj J, Zurner N, Pawelczyk N. An increase in plasma brain derived neurotrophic factor levels is related to n-3 poly unsaturated fatty acid efficacy in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized clinical trial. Psychopharmacology. 2019; 236: 2811-2822. doi: 10.1007/s00213-019-05258-4
66. Rao JS, Ertley RN, Lee HJ, De Mar JC, Arnold JT, Rapoport SJ, et al. N-3 poly unsaturated fatty acid deprivation in rats decreased frontal cortex BDNF via p38 MAPK-dependent mechanism. Mol Psychiatry. 2007; 12: 36-46. doi: 10.1038/sj.mp.4001888
67. Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, et al. Omega -3 fatty acids prevent inflammation and metabolic syndrome in mice. Immunity. 2013; 38: 1154-1163. doi: 10.1016/j.immuni.2013.05.015
68. Chassaing B, Ley RE, Gewirtz AT. Intestinal epithelial cell toll like receptors 5 regulates the intestinal microbiota to prevent low grade inflammation and metabolic syndrome in mice. Gastroenterology. 2014; 147: 1363-1377.e17. doi: 10.1053/j.gastro.2014.08.033
69. Rakoff-Nahoum S, Paglinno J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll like receptors is required for intestinal homeostasis. Cell. 2004; 118: 229-241. doi: 10.1016/j.cell.2004.07.002
70. Hug H, Mohajeri MH, La Fata G. Toll like receptors: Regulators of the immune response in the human gut. Nutrients. 2018; 10: 203. doi: 10.3390/nu10020203
71. Yun S, Reynolds RP, Masiulis L, Eisch AJ. Re-evaluating the link between the neuropsychiatric disorders and dysregulated adult neurogenesis. Nat Med. 2016; 22: 1239-1247. doi: 10.1038/nm.4218
72. Hwang DH, Kim JA, Lee JY. Mechanisms of activation of toll like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Eur J Pharmacol. 2016; 785: 24-35. doi: 10.1016/j.ejphar.2016.04.024
73. Lopez-Morono J, Garcia-Carpintero S, Gomez-Delgado F, Jimenez-Lucena R,Vals-Delgado C, Alcala –Diaz JF, et al. Endotoxaemia is modulated by quantity and quality of dietary fats in older adults. Exp Gerontol. 2018; 109: 119-125. doi: 10.1016/j.exger.2017.11.006
74. Camargo A, Delgado-Lista J, Garcia-rios A, Cruz-Teno C, Yubero-Serrano EM, Perez-Martinez P, et al. Expression of pro inflammatory, proatherogenic genes is reduced by mediterranean diet in elderly people. Br J Nutr. 2012; 108: 500-508. doi: 10.1017/S0007114511005812
75. Ba ckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101: 15718-15723. doi: 10.1073/pnas.0407076101
76. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009; 1(6): 6ra14. doi: 10.1126/scitranslmed.3000322
77. Raimondi F, Santoro P, Barone MV, Pappacoda S, Barretta ML, Nanaya kkara M, et al. Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGRF activation. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G906-G913. doi: 10.1152/ajpgi.00043.2007
78. Lam YY, Ha CW, Campbell CR, Mitchell AJ, Dinudom A, Oscarsson J, et al. Increased gut permeability and microbiota changes associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One. 2012; 7(3): e34233. doi: 10.1371/journal.pone.0034233
79. Charpentier c, Chan R, Salameh E, Mbodji K, Ueno A, Coeffier M, et al. Dietary n-3 PUFAs may attenuate experimental colitis. Mediators Inflamm. 2018; 2018: 8430614. doi: 10.1155/2018/8430614
80. Xiao G, Tang L, Yuan F, Zhu W, Zhang S, Liu Z, et al. Eicosa pentaenoic acid enhances heat stress-impaired intestinal epithelial barrier function in Caco -2 Cells. PLoS One. 2013; 8: e73571. doi: 10.1371/journal.pone.0073571
81. Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.Seminal Immunol. 2015; 27: 200-215. doi: 10.1016/j.smim.2015.03.004
82. Rey C, Delpech JC, Madore C, Nadjar A, Greenhalgh AD, Amadieu C, et al. Dietary n-3 long chain PUFAs supplementation promotes a pro-resolving oxylipin profile in the brain. Brain Behav Immun. 2019; 76: 17-27. doi: 10.1016/j.bbi.2018.07.025
83. Serhan CN, Levy BD. Resolvins in inflammation: Emergence of the pro-resolving super mediators of mediators. J Clin Investig. 2018; 128: 2657-2669. doi: 10.1172/JCI97943
84. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: Dual anti inflammatory and pro-resolution lipid mediators. Nat Rev Immun. 2008; 8: 349-361. doi: 10.1038/nri2294
85. Ishida T, Yoshida M, Arita M, Nishitani Y, Nishiumi S, et al. Resolvins E1, an endogenous lipid mediator derived from eicosa pentaenoic acid, prevents dextran sodium–induced colitis. Inflamm Bowel Dis. 2010; 16: 87-95. doi: 10.1002/ibd.21029
86. Chiang N, Barnaeva E, Hu X, Marugan J, Southall N, Ferrer M, et al. Identification of chemotype agonists for human resolvins D1 receptor DRV1 with pro-resolving functions. Cell Chem Biol. 2019; 26: 244-254.e4. doi: 10.1016/j.chembiol.2018.10.023
87. Deyama S, Ishikawa Y, Yoshi kawa K, Shimoda K, Ide S, Fukuda H, et al. Resolvins D1 and D2 reverse lipopolysaccharide–induced depression–like behaviors through the mTOR signaling pathway. Int J Neuropsychopharmacol. 2017; 20: 575-584. doi: 10.1093/ijnp/pyx023
88. Deyama S, Shimoda K, Ikeda H, Fukuda H, Shuto S, Minami M, et al. Resolvins E3 attenuates lipopolysaccharide–induced depression like behaviors in mice. J pharmacol Sci. 2018; 138: 86-88. doi: 10.1016/j.jphs.2018.09.006
89. Deyama S, Shimoda K, Suzuki H, Ishikawa Y, Ishimura K, Fukuda H, et al. Resolvins E1/E2 ameliorate lipopolysaccharide–induced depression–like behaviors via chemR23. Psychopharmacology. 2018; 235: 329-336. doi: 10.1007/s00213-017-4774-7
90. Robertson RC, Seira-Oriach C, Murphy LK, Moloney GM, Cryan JF, Dinan TG, et al. Omega 3 poly unsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun. 2017; 116: 9644-9651. doi: 10.1016/j.bbi.2016.07.145
91. Provensi G, Schmidt SD, Boehme M, Bastiaanssen TFS, Rani B, Costa A, et al. Preventing adolescent stress–induced cognitive and microbiome changes by diet. Proc Natl Acad Sci U S A. 2019; 116: 9644-9651. doi: 10.1073/pnas.1820832116
92. Skosnik PD, Yao JK. From membrane phospholipids to altered neurotransmitters: Is arachidonic acid a nexus in the pathophysiology of schizophrenia? Prostaglandins Leukot Essent Fat Acids. 2003; 69: 367-384. doi: 10.1016/j.plefa.2003.08.008
93. Zheng W, Cai DB, Yang XH, Ungvari GS, Ng CH, Muller N, et al. Adjunctive celecoxib for schizophrenia? A meta-analysis of randomized, double blind, placebo controlled trials. J Psychiatry Res. 2017; 92: 139-146. doi: 10.1016/j.jpsychires.2017.04.004
94. Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, Drago F, et al. Omega 3 fatty acids and depression:Scientific evidence and biological mechanisms. Oxid Med Cell Longev. 2014; 2014: 313570. doi: 10.1155/2014/313570
95. Tamiji J, Crawford DA. The neurobiology of lipid metabolism in autism spectrum disorders. Neurosignals. 2010; 18: 98-112. doi: 10.1159/000323189
96. Hoen WP, Lijmer JG, Duran M, Wanders RJA, Van Beveren NJM, De Haan L. Red blood cell Omega 3 polyunsaturated fatty acids measured in red blood cells and schizophrenia: A meta-analysis. Psychiatry Res. 2013; 207: 1-12. doi: 10.1016/j.psychres.2012.09.041
97. Montenos-Rueda L,Canete-CrespilloJ, Palma-Sevillano C, Gine serven E. Erythrocyte membrane polyunsaturated fatty (pufa) levels in a sample of patients with schizophrenia and relation with clinical and progression values. Actas Esp Psiquiatr. 2015; 43: 170-176.
98. Chalon S. Omega 3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids. 2006; 75: 259-269. doi: 10.1016/j.plefa.2006.07.005
99. El Sayed El Sisi A, Sokkar SS, El Sayed El Sayed M, Sayed Ramadan E, Osman EY. Celecoxib and Omega 3 fatty acids alone and in combination with risperidone affect the behaviour and brain biochemistry in amphetamine induced model of schizophrenia. Biomed Pharmacother. 2016; 82: 425-431. doi: 10.1016/j.biopha.2016.05.024
100. Sublette ME, Galfalvy HC, Hibbeln JR, Keilp JG, Malone KP, Oquendo MA, et al. Poly unsaturated fatty acid associations with dopaminergic indices in major depressive disorders. Int J Neuropsychopharmacol. 2014; 17: 383-391. doi: 10.1017/S1461145713001399
101. Camardese G, De Risio L, De Nicola M, Pucci L, Cocciolillo P,Brio P, et al. Changes of dopamine transporter availability in depressed patients with and without anhedonia: AI-Nω-fluoropropyl-carbomethoxy-3β-(4iodophenyl) tropane SPECT study. Neuropsychobiology. 2014; 70: 235-243. doi: 10.1159/000368117
102. Grace AA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci. 2016; 17: 524. doi: 10.1038/nrn.2016.57
103. Du Bois TM, Deng C, Bell W, Huang X. Fatty Acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience. 2006; 139: 1397-1403. doi: 10.1016/j.neuroscience.2006.02.068
104. Eisenhofer G, Anemon A, Friberg P, Hooper D, Frandriks L, Lonroth H, et al. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab. 1997; 82: 3864-3871. doi: 10.1210/jcem.82.11.4339
105. Xue R, Zhang H, Pan J, Du Z, Zhou W, Zhang Z, et al. Peripheral dopamine controlled by gut microbes inhibits invariant natural killer cell-mediated hepatitis. Front Immunol. 2018; 9: 2398. doi: 10.3389/fimmu.2018.02398
106. Nishino R, Mikami K, Takahashi H, Tamonnaga S, Furuse M, Hiramoto T, et al. Commensal microbiota modulates murine behaviours in a strictly contamination free environment confirmed by culture based methods. Neurogasteroenterol Motil. 2013; 25: 521-528. doi: 10.1111/nmo.12110
107. Crumeyrolle-Arias M, Jaglin M, Bruneau A, Vancassel S, Cardona A, Dauge V, et al. Absence of the gut microbiota enhances anxiety like behaviour and neuroendocrine responses to acute stress in rats. Psychoneuroendocrinology. 2014; 42: 207-217. doi: 10.1016/j.psyneuen.2014.01.014
108. Sher L, Oquendo MA, Li S, Burke AK, Grunebaum MF, Zalsman G, et al. Higher cerebrospinal fluid homovanillic acid levels in depressed patients with comorbid post traumatic stress disorder.Eur Psychopharmacol. 2005; 15: 203-209. doi: 10.1016/j.euroneuro.2004.09.009
109. Hoban AE, Moloney RD, Golubeva AV, McVey Neufeld KA, O’Sullivan O, Patterson E, et al. Behavioral and neurochemical consequences of chronic gut microbiota depletion during adulthood in rat. Neuroscience. 2016; 339: 463-477. doi: 10.1016/j.neuroscience.2016.10.003
110. Yuan X, Zhang P, Wang Y, Liu Y, Li X, Kumar BU, et al. Changes in metabolism and microbiota after 24 week risperidone treatment in drug naive, normal weight patients with first episode of schizophrenia. Schizophr Res. 2018; 201: 299-306. doi: 10.1016/j.schres.2018.05.017
111. Cocurello R, Moles A. Potential mechanisms of atypical antipsychotic induced-metabolic derangement: Clues for understanding obesity and novel drug design. Pharmacol Ther. 2010; 127: 210-251. doi: 10.1016/j.pharmthera.2010.04.008
112. Robertson RC, Seira-Oriach C, Murphy LK, Moloney GM, Cryan JF, Dinan TG, et al. Deficiency of essential dietary n-3 PUFA disrupts the caecal microbiome and metabolome in mice. Br J Nutr. 2017; 118: 959-970. doi: 10.1017/S0007114517002999
113. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, et al. Normal gut microbiota modulate brain development and behaviour. Proc Natl Acad Sci U S A. 2011; 108: 3047-3052. doi: 10.1073/pnas.1010529108
114. Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, et al. Gut bacteria selectively promoted by dietary fibres alleviate type 2 diabetes. Science. 2018; 359: 1151-1156. doi: 10.1126/science.aao5774
115. Cardoso HD, Dos Santos EFJr, De Santana DF, Goncalves -Pimentel C, Angelim MK, Isaac AR, et al. Omega 3 Deficiency and neurodegeneration in the substantia nigra: Involvement of increased nitric oxide production and reduced BDNF expression. Biochim Biophys Acta Gen Subj. 2014; 1840: 1902-1912. doi: 10.1016/j.bbagen.2013.12.023
116. Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013; 54: 2325-2340. doi: 10.1194/jlr.R036012
117. Horuchi Y, Kimura R, Kato N, Fuiji T, Seki M, Endo T, et al. Evolutional study on acetyl choline expression. Life Sci. 2003; 72: 1745-1756. doi: 10.1016/s0024-3205(02)02478-5
118. Terry N, Margolis KG. Serotonergic mechanisms regulating the GI tract: Experimental evidence and therapeutic relevance. Handb Exp Pharmacol. 2017; 239: 319-342. doi: 10.1007/164_2016_103
119. David LA Maurice CF, Carmody RN, Gootenberg DB, Burton JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014; 505: 559-563. doi: 10.1038/nature12820
120. Uranga JA, Lopez-Miranda V, Lombo E, Abalo R. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel diseases. Pharmacol Rep. 2016; 68: 816-826. doi: 10.1016/j.pharep.2016.05.002
121. Hold GL. Western lifestyle: A master manipulator of the intestinal microbiota? Gut. 2014; 63: 5-6. doi: 10.1136/gutjnl-2013-304969
122. Martinez –Medina M, Denizot J, Dreux N, Robin F, Billard E, Bonnet R, et al. Western diet induces dysbiosis with increased e.coli in CEABAC 10mice, alters host barrier function favouring AIEC colonisation. Gut. 2014; 63: 116-124. doi: 10.1136/gutjnl-2012-304119
123. Tang MHW, Wang Z, Levison BS, Korth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism in phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013; 368: 1575-1584. doi: 10.1056/NEJMoa1109400
124. Pandyala S, Walker JM, Holt PR. A high fat diet is associated with endotoxaemia that originates from the gut. Gasteroenterology. 2012; 142: 1100-1101. e2. doi: 10.1053/j.gastro.2012.01.034
125. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Grandoux JJ, et al. Faecalibacterium prausnitzii is an-anti inflammatory commensal bacterium identified by gut microbiota analysis of Crohns disease patients. Proc Natl Acad Sci U S A. 2008; 105: 16731-1736. doi: 10.1073/pnas.0804812105
126. Agus A, Denizot J, Thevenot J, Martinez –Medina M, Massier S, Sauvanet P, et al. Western diet induces a shift in microbiota composition enhancing susceptibility to adherent invasive E.Coli infection and Intestinal inflammation. Sci Rep. 2016; 6: 19032. doi: 10.1038/srep19032
127. Turnbaugh PJ, Backhead F, Fulton L, Gordon JI. Diet induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008; 3: 213-223. doi: 10.1016/j.chom.2008.02.015
128. Parada-Venegas D, De la Fuente MK, Landskron G, Gonzalez MJ, Quera R, Dijkstra G, et al. Short chain fatty acids (SCFA)-Mediated gut epithelial and immune regulation and its reversal for inflammatory bowel diseases. Front Immunol. 2019; 10: 277. doi: 10.3389/fimmu.2019.00277
129. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, et al. The microbial metabolites, Short chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013; 341: 569-573. doi: 10.1126/science.1241165
130. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, et al. Activation of Gpr 109a, receptor for niacin and the commensal ,metabolite butyrate suppresses colonic inflammation and carcinogenesis. Immunity. 2014; 40: 128-139. doi: 10.1016/j.immuni.2013.12.007 Sci Rep. 2018; 8: 74
131. Laurraufie P, Martin-Gallausiaux C, Lapaque N, Dore J, Gribble FM, Gribble FM, Reimann F, et al. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Nature. 2018; 8(1). doi: 10.1038/s41598-017-18259-0
132. Liu J, Sun J, Wang F, Yu X, Ling Z, Li H, et al. Neuroprotective effects of Clostridium butyricum against Vascular dementia in mice via metabolic butyrate. Biomed Res Int. 2015; 2015: 412946. doi: 10.1155/2015/412946
133. Byrne CS, Chambers ES, Alhabeeb H, Chhina N, Morrison DJ, Preston T, et al. Increased colonic propionate reduces anticipatory reward responses in the human striatum to high energy foods. Am J Clin Nutr. 2016; 104: 5-14. doi: 10.3945/ajcn.115.126706
134. Benus RFJ, Van der Werf TS, Welling GW, Judd PA, Taylor MA, et al. Association between Faecalibacterium prasnitzii and dietary fibres in colonic fermentation in healthy human subjects. Br J Nutr. 2010; 104: 693-700. doi: 10.1017/S0007114510001030
135. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lette. 2009; 294: 1-8. doi: 10.1111/j.1574-6968.2009.01514.x
136. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immunol. 2015; 48: 186-194. doi: 10.1016/j.bbi.2015.03.016
137. Zhang J, Zhong Q. Histone deacetylase inhibitors and cell death. Cell Mol Life Sci. 2014; 71: 3885-3901. doi: 10.1007/s00018-014-1656-6
138. Valvassori S, Varela R, Arent C, Dal-Pont G, Bobsin T, Budni J, et al. Sodium butyrate function as an antidepressant and improves cognition with enhanced neurotrophic expression in m odels of maternal deprivation and chron ic mild stress. Curr Neurovasc Res. 2014; 11: 3885-3901. doi: 10.2174/1567202611666140829162158
139. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neuro Sci. 2007; 8: 355-367. doi: 10.1038/nrn2132
140. Herre M, Korb E. The chromatin landscape of neuronal plasticity. Curr Opin Neurobiol. 2019; 59: 79-86. doi: 10.1016/j.conb.2019.04.006
141. Machado-Veira R, Ibrahim L, Zarate C. Histone deacetylases and mood disorders: Epigenetic programming in gene-environmental interactions. CNS Neurosci Ther. 2011; 17: 699-704. doi: 10.1111/j.1755-5949.2010.00203.x
142. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci. 2006; 9: 519-525. doi: 10.1038/nn1659
143. Zhang J, Yao W, Dong C, Yang C, Ren Q, Ma H, et al. Comparison of ketamine, 7,8-dihydroxy flavones, and ANA 12 antidepressant effects in the social defeat stress model of depressio. Psychopharmacology (Berl). 2015; 232: 4325-335. doi: 10.1007/s00213-015-4062-3
144. Wu X, Chen PS, Dallas S, Wilson B, Block MI, Wang CC, et al. Histone deacetylase inhibitors upregulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol. 2008; 11: 1123-1134. doi: 10.1017/S1461145708009024
145. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, et al. The gut microbiota influences blood brain barrier permeability in mice. Sci Transl Med. 2014; 6: 263ra158. doi: 10.1126/scitranslmed.3009759
146. Yamawaki Y, Fuchikami M, Morinobu S, Segawa M, Matsumoto T, Yamawaki S. Antidepressant-like effect of Sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. World J Biol Psychiatry. 2012; 13: 458-467. doi: 10.3109/15622975.2011.585663
147. Han A, Sung YB, Chung SY, Kwon MS. Possible additional Antidepressant-like mechanism of Sodium butyrate: Targeting the hippocampus. Neuropharmacology. 2014; 81: 292-302. doi: 10.1016/j.neuropharm.2014.02.017
148. Hao Z, Wang W,Guo R, Liu H. Faecalibacterium prasnitzii (ATCC27766) has preventive and therapeutic effects on chronic unpredictable stress-induced depression –like and anxiety like behaviour in rats. Psychoneuroendocrinology. 2019; 104: 132-142. doi: 10.1016/j.psyneuen.2019.02.025
149. Yu Z, Chen ZY. The role of BDNF in depression on the basis of its location in neural circuitry. Acta Pharmacol Sin. 2011; 32: 3-11. doi: 10.1038/aps.2010.184
150. Martinowich K, Lu B. Interaction between BDNF and serotonin: Role in mood disorders. Neuropsychopharmacology. 2008; 33: 73-83. doi: 10.1038/sj.npp.1301571
151. Morita K, Gotohda T, Armochi H, Lee MS, Her S. Histone deacetylase inhibitors promote neurosteroid –mediated cell differentiation and enhance serotonin-stimulated brain derived neurotrophic factor gene expression in rat C6 glioma cells. J Neurosci Res. 2009; 87: 2608-2714. doi: 10.1002/jnr.22072
152. Sun J, Wang F, Hong G, Pang M, Xu H, Li H, et al. Antidepressant-like effects of Sodium butyrate and its possible mechanisms of actions in mice exposed to chronic unpredictable mild stress. Neurosci Lett. 2016; 618: 159-166. doi: 10.1016/j.neulet.2016.03.003
153. Intlekofer KA, Berchtold NC, Malvaez M, Carlos AJ, McQown SC, Cunningham MJ, et al. Exercise and Sodium butyrate transform a subthreshhold learning event into long term memory via a brain derived neurotrophic factor-dependent mechanism. Neuropsychopharmacology. 2013; 38: 2027-2034. doi: 10.1038/npp.2013.104
154. Hoyles L, Snelling T, Umlai UK, Nicholson JK, Carding SR, Glen RC, et al. Microbiome –host system interactions: Positive effects of propionate upon the blood brain barrier. Microbiome. 2018; 6: 55. doi: 10.17863/CAM.24535
155. Szczesniak O, Hestad K, Hanssen JF, Rudi K. Isovaleric acid in stool correlates with human depression. Nutr Neurosci. 2016; 19: 279-283. doi: 10.1179/1476830515Y.0000000007
156. Wang Y, Hsu TT, Zhao JJ, Nishimura S, Fuller GG, Sonner JM. Isovaleric, methyl malonic, and propionic acid decrease anaesthetic ec50 in tadpoles, modulate glycine receptor function, and interact with the lipid 1,2diaplmitoyl-Sn-glycero-3-phosphocholine. Anaesth Analg. 2009; 108: 1538-1545. doi: 10.1213/ane.0b013e31819cd964
157. Serefko A, Szopa A,Wlaz A,Wosko S, Wlaz P, Poleszak E. Synergistic Antidepressant-like effects of the joint administration of caffeine and NMDA receptor ligands in the forced swim test in mice. J Neural Transm. 2016; 123: 463-472. doi: 10.1007/s00702-015-1467-4
158. Buie T, Campbell DB, Fuchs GJ, Furuta GT, Levy J, VandeWater J, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: A consensus report. Pediatrics. 2010; 125 Suppl 1: S1-S18. doi: 10.1542/peds.2009-1878C
159. Ashwood P, Kaul A, Patterson P, Jones NE, Coury DL, Fuchs G, et al. Gastrointestinal conditions in children with autism spectrum disorders: Developing research agenda. Paediatrics. 2012; 130: S160-S168. doi: 10.1542/peds.2012-0900N
160. McElhanon BO, McC racken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorders: A meta-analysis. Pediatrics. 2014; 133: 872-883. doi: 10.1542/peds.2013-3995
161. Bolte ER. Autism and clostridium tetani. Med Hypothesis. 1998; 51: 133-144. doi: 10.1016/s0306-9877(98)90107-4
162. Luna RA, Oezguen N, Balderas M, Venkatachalam A,Runge JK,Versalovic J, et al. Distinct microbiome –neuroimmune signatures with functional abdominal pain in children with autism spectrum disorders. Cell Mol Gastroenterol Hepatol. 2017; 3: 218-230. doi:10.1016/j.jcmgh.2016.11.008
163. Tomova A, Husarova V, Lakatsova S, Bakos J, Vikova B, Babinska K, et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav. 2015; 138: 179-187. doi: 10.1016/j.physbeh.2014.10.033
164. Finegold SM, Dowd SE, Gontcharova V, Liu C, Hanley KE, Wolcott RD, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010; 16: 444-453. doi: 10.1016/j.anaerobe.2010.06.008
165. Emanuele E, Orsi P, Boso M, Broglia D, Brondino N, Barale F, et al. Low grade endotoxemia in patients with severe autism. Neurosci Lett. 2010; 471: 162-165. doi: 10.1016/j.neulet.2010.01.033
166. Plaza-Diaz J, Gomez-Fernandez A, Chueca N, De La Torre-Aguilar MJ, Gil A, Perez-Nevero JL, etal. Autism Spectrum Disorcer (ASD) with and without mental regression is associated with changes in the fecal microbiota. Nutrients. 2019; 11: 337. doi: 10.3390/nu11020337
167. Shin NR, Whon TW, Bae JW. Proteobacteria: Microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015; 33: 496-503. doi: 10.1016/j.tibtech.2015.06.011
168. Suh JH, Walsh WJ, McGinnis WR, Lewis A, Ames BN, Altered sulphur amino acid metabolism in immune cells of children diagnosed with autism. Am J Biotech Biotechnol. 2008; 4: 105-113. doi: 10.3844/ajbbsp.2008.105.113
169. DeAngelis M, Francavilla R, Picolo M, De Giacomo A, Gobetti M. Autism spectrum disorcers and intestinal microbiota. Gut Microbes. 2015; 6: 207-213. doi: 10.1080/19490976.2015.1035855
170. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiata modulate behavioural and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013; 55: 1451-1463. doi: 10.1016/j.cell.2013.11.024
171. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Elevated fecal short chain fatty acids and ammomnia concentrations in children with autism spectrum disorcers. Dig Dis Sci. 2012; 57: 2096-2102. doi: 10.1007/s10620-012-2167-7
172. Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Commensal clostridia: Leading players in the maintainance of gut homeostasis. Gut Pathol. 2013; 5: 23. doi: 10.1186/1757-4749-5-23
173. Rossignoi DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorcers: A systematic review and meta-analysis. Mol Psychiatry. 2012; 17: 290-314. doi: 10.1038/mp.2010.136
174. Abdelli LS, Samsam A, Naser A. Propionic acid induces Gliosis and neuroinflammation through modulation of PTEN/AKT Pathway in Autism Spectrum Disorcer. Sci Rep. 2019; 9: 8824. doi: 10.1038/s41598-019-45348-z
175. Schultz SR, MacFabe DF. Propionic acid Animal model of Autism. In: Comprehensive Guide to Autism. New York, NY, USA: Springer; 2014: 1755-1778. doi: 10.1007/978-1-4614-4788-7_106
176. MacFabe DF. Short chain fatty acids fermentation products of the gut microbiome: Implications in autism spectrum Disorder. Micob Ecol Heal Dis. 2012; 23: 19260. doi: 10.3402/mehd.v23i0.19260
177. Berding K, Donovan SM. Diet can impact Microbiata composition in children with autism spectrum disorcers. Front Neurosci. 2018; 12: 515. doi: 10.3389/fnins.2018.00515
178. Doenas C. Dietary interventions for autism spectrum disorcer: New perspewctives from gut-brain axis. Physiol Behav. 2018; 194: 577-582. doi: 10.1016/j.physbeh.2018.07.014
179. Schwarz E, Maukonen J, Hyytiainen T, Kieseppa T, Oresic M, Sabunciyan S, et al. Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response. Schizophr Res. 2018; 192: 398-403. doi: 10.1016/j.schres.2017.04.017
180. Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, et al. The gut microbiome from patient with Schizophrenia modulates the glutamate-glutamine –GABA cycle and Schizophrenia –relevant behaviors in mice. Sci Adv. 2019; 5: eaau8317. doi: 10.1126/sciadv.aau8317
181. Savignac HM, Corona G, Mills H, Chen L, Spencer JPE, Tzortzis G, et al. Probiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine. Neurochem Int. 2013; 63: 756-764. doi: 10.1016/j.neuint.2013.10.006
182. Nieto R, Kukuljan M, Silva H. BDNF and Schizophrenia.From neurodevelopment to neuronal plasticity ,learning and memory. Front Psychiatry. 2013; 4: 45. doi: 10.3389/fpsyt.2013.00045
183. Numakawa T, Odaka H, Adachi NH. Actions of brain derived neurotrophic factor in the neurogenesis and neuronal function in the involvement in the pathophysiology of brain diseases.Int J Mol Sci. 2018; 19: 3650. doi: 10.3390/ijms19113650
184. Bistoletti M, Caputi V, Baranzini N, Marchesi N, Filpa V, Marsilio I, et al. Antibiotic treatment induced dysbiosis differently affects BDNF and TrkB expression in the brain and gut of juvenile mice. PLoS One. 2019; 14: e0212856. doi: 10.1371/journal.pone.0212856
185. Barichello T, GenerosoJS, Simoes LR, Faller CJ, Ceretta RA, Petronilho F, et al. Sodium butyrate prevents memory impairment by re-establishing BDNF and GDNF expression in experimental pneumococcal meningitis. Mol Neurobiol. 2015; 52: 734-740. doi: 10.1007/s12035-014-8914-3
186. Chriett S, Dabek A, Wojtala M, Vidal H, Balcerczy kA, Pirola L. Prominent action of butyrate over β-hydroxy butyrate as Histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule. Sci Rep. 2019; 9: 742. doi: 10.1038/s41598-018-36941-9
187. Muller N. Inflammation in schizophrenia: Pathologic effects and therapeutic considerations. Schizophr Bull. 2018; 44: 973-982. doi: 10.1093/schbul/sby024
188. Snyder MA, Gao WJ. NMDA hypofunction as a convergence point for the progression of symptoms of schizophrenia. Front Cell Neurosci. 2013; 7: 31. doi: 10.3389/fncel.2013.00031
189. Tarabeux J, Kabir O, Gauthier J, Hamdan FF, Xiong L, Piton A, et al. Rare mutations in N-methyl-d-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl Psychiatry. 2011; 1: e55. doi: 10.1038/tp.2011.52
190. Evans SJ, Bassis CM, Hein R, Assari S, Flowers SA, Kelly MB, et al. The gut Microbiome composition associates with bipolar disorders and illness severity. J Psychiatry Res. 2017; 87: 23-29. doi: 10.1016/j.jpsychires.2016.12.007
191. Menni C, Zierer J, Pallister T, Jackson MA, Long T, Mohney RP, et al. Omega -3- fatty acids correlate with gut microbiome diversity and production of N-carbyl glutamate in middle aged and elderly women. Sci Rep. 2017; 7: 11079.
192. Davis DJ, Hecht PM, Jasarevic E, Bevdersdorf DQ, Will MJ, Fristche K, Gillespie CH. Sex specific effects of docosahexaenoic acid (DHA), on the Microbiome and behaviour of socially isolated mice. Brain Behav Immunol . 2017; 59: 38-48. doi: 10.1016/j.bbi.2016.09.003